» Articles » PMID: 28914251

Clinical and Radiographic Comparison of Platelet-rich Fibrin and Mineral Trioxide Aggregate As Pulpotomy Agents in Primary Molars

Overview
Specialty Dentistry
Date 2017 Sep 16
PMID 28914251
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: This study aimed to evaluate and compare the Platelet-rich fibrin (PRF) and Mineral trioxide aggregate (MTA) as a pulpotomy agent in primary molars.

Material And Methods: In this study, 50 primary molars from 50 healthy children aged 5-9 years requiring pulpotomy were randomly allocated into two groups. In PRF group, after coronal pulp removal and hemostasis, remaining pulp tissue was covered with PRF preparation. In the MTA group, the pulp stumps were covered with MTA (Pro Root MTA-Root Canal Repair Material, Dentsply International Inc.) paste obtained by mixing MTA powder with sterile water at a 3:1 powder to water ratio. All teeth were restored with reinforced zinc oxide eugenol base and glass - ionomer cement. Stainless steel crowns were given in both groups 24 h after treatment. Clinical evaluation was undertaken at 1, 3, and 6 months intervals whereas radiographic evaluation of the treated teeth was carried out at the interval of 6 months.

Results: By the end of 6 months, the overall success rate was 90% in PRF group and 92% in MTA Group. A statistically significant difference was observed between the groups at 6 months of follow-up (P < 0.05). The results were statistically nonsignificant between the groups (P > 0.05).

Conclusion: Radiographic and clinical outcome in PRF group could suggest it as an acceptable alternative in pulpotomy of primary teeth. PRF holds a promising future in the area of primary tooth vital pulp therapy.

Citing Articles

To Evaluate and Compare Platelet-rich Fibrin and Mineral Trioxide Aggregate as Direct Pulp Capping Agents in Primary Molars: A Randomized Prospective Clinical Study.

Tiwari T, Tyagi P, Tiwari S, Mali S, Moudgalya M, Jaiswal N Int J Clin Pediatr Dent. 2024; 17(Suppl 1):S25-S29.

PMID: 39185252 PMC: 11343996. DOI: 10.5005/jp-journals-10005-2859.


Outcome assessment methods of bioactive and biodegradable materials as pulpotomy agents in primary and permanent teeth: a scoping review.

Elhamouly Y, Adham M, Dowidar K, El Backly R BMC Oral Health. 2024; 24(1):496.

PMID: 38678210 PMC: 11055312. DOI: 10.1186/s12903-024-04221-w.


Platelet-Rich Fibrin (PRF) and its Application in Dentistry: A Literature Review.

Goswami P, Chaudhary V, Arya A, Verma R, Vijayakumar G, Bhavani M J Pharm Bioallied Sci. 2024; 16(Suppl 1):S5-S7.

PMID: 38595504 PMC: 11000897. DOI: 10.4103/jpbs.jpbs_435_23.


Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: a randomized clinical trial.

Yilmaz S, Keles S Eur Oral Res. 2023; 57(3):144-150.

PMID: 37929220 PMC: 10622155. DOI: 10.26650/eor.2023950004.


Pulp Therapy of Primary Dentition; its Relevance despite Insufficient Histological Evidence: A Review.

Sanusi S, Al-Bataynehb O Iran Endod J. 2023; 18(1):15-40.

PMID: 36751408 PMC: 9900146. DOI: 10.22037/iej.v18i1.34931.